Why the study?
BNP and NT-proBNP are widely reviewed in clinical medicine, but few articles have reviewed their application as biomarkers of cardiac dysfunction in forensic medicine.
Key points are not available for this paper at this time.
Design
Review article
Answers are grounded in this paper and cite their sources.
Highlights dual clinical-forensic biomarker role; leaves open prospective validation of cutoffs and standardization.
Currently, brain natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) are widely used as diagnostic biomarkers for heart failure (HF) and cardiac dysfunction in clinical medicine. They are also used as postmortem biomarkers reflecting cardiac function of the deceased before death in forensic medicine. Several previous studies have reviewed BNP and NT-proBNP in clinical medicine, however, few articles have reviewed their application in forensic medicine. The present article reviews the biological features, the research and application status, and the future research prospects of BNP and NT-proBNP in both clinical medicine and forensic medicine, thereby providing valuable assistance for clinicians and forensic pathologists.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: